- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02849665
Immediate Effect of Kangaroo Position in Electromyographic Activity and Microcirculation of Newborn Preterm
August 12, 2017 updated by: Kaísa Trovão Diniz, Professor Fernando Figueira Integral Medicine Institute
Immediate Effect of Kangaroo Position in Electromyographic Activity and Microcirculation of Newborn Preterm: A Randomized Clinical Trial.
Introdution: The Kangaroo Mother Care is a perinatal care model for preterm and low weight newborn.
The Kangaroo Position is the main feature of this method.
The infant should be lightly dressed, in prone position and upright against the torax of the parents.
Researches provides evidence that the Kangaroo Position induces an increase in myoelectric activity of preterm newborn.
However, it is unknown how long the newborn should remain in the kangaroo Position so that ocurr changes in electromyographic.
An increase in electromyographic activity was observed after 24 hours or more of submission to the Position Kangaroo, however period lower of submission to the Position Kangaroo have not been evaluated yet.
Also unknown are the physiological mechanisms that cause this muscle response.
One hypothesis would be the increase in temperature caused by skin to skin contact which could improve circulation in small vessels with direct influence on the infusion and nutrition of muscle tissue.
Objective: Evaluate the immediate effect of Kangaroo position in the electromyographic activity and microcirculation of preterm newborn.
Method: It will be a randomized and controlled trial from August 2016 to February 2017 with newborn preterm admitted at the Kangaroo Unit, IMIP.
Newborns eligible according to the inclusion and exclusion criteria will be randomized into two groups: Kangaroo Group (experimental group) and Not Kangaroo Group (control group).
The data of the electromyographic activity and the microcirculatory parameters will be assessed and recorded in three stages: before the Kangaroo position, one and three hours after of continuous submission in the Kangaroo Position (for the group of cases) and before the Kangaroo position, one and four after the three assessments (for the control group).
In the control group, the preterm newborns will be not submitted to Kangaroo position until the completion of the last and third evaluation.
The acquisition of the electromyographic signal will be conducted through an equipment electromyography Miotool 400® brand (Miotec Equipamentos Biomédicos - Brasil).
To assess microcirculation will be used for the white light spectroscopy method through the drive moorVMS-OXY®.
The project was submitted and approved by Ethics Committee for Research on Human Beings of IMIP (52381915.5.0000.5201).
This study is part of a anchor project approved by Conselho Nacional de Desenvolvimento Científico e Tecnológico- CNPq (process 458163/2014-7).
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kaísa T. Diniz, PhD student
- Phone Number: +55 81 999328432
- Email: kaisa.tdz@hotmail.com
Study Contact Backup
- Name: José E. Cabral Filho, PhD
- Phone Number: + 55 81 22122 4122
- Email: eulalio@imip.org.br
Study Locations
-
-
Pernambuco
-
Recife, Pernambuco, Brazil, 50070-550
- Recruiting
- Unidade Canguru
-
Contact:
- Geisy Maria Souza Lima, MD
- Phone Number: 55 81 21224125
- Email: canguru@imip.org.br
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 8 months (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- a gestational age of 27-34 weeks;
- corrected age of until 35 weeks at the time of the first examination;
- had not previously been in the kangaroo position;
Exclusion Criteria:
- Apgar lower than 7 in the 5th min;
- a history of grade III or IV intracranial haemorrhage (diagnosed by way of transfontanelar ultrasound and included in the medical records);
- seizures;
- congenital infections (cytomegalovirus, rubella, toxoplasmosis, syphilis and vertically transmitted HIV)
- malformations of the central nervous system (hydrocephaly and genetic syndromes), infections of the central nervous system (meningitis or encephalitis);
- congenital cardiopathy;
- traumas during delivery (injuries to the brachial plexus, dislocation of the hip and pelvis fractures) and gastro-oesophageal reflux disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Kangaroo Position
The newborn remains in a vertical position, with limbs flexed, dressed in light clothes, maintaining skin-to-skin contact and the face on the adult's thorax.
|
|
No Intervention: Not Kangaroo Position
The newborns will be not placed in the position Kangaroo.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Electromyographic activity
Time Frame: 15 minutes
|
Measure of the changes in electric potential of muscle.
|
15 minutes
|
Tissue oxygen saturation - SO2
Time Frame: 5 minutes
|
5 minutes
|
|
Relative oxygenated haemoglobin concentration - oxyHb
Time Frame: 5 minutes
|
5 minutes
|
|
Relative deoxygenated haemoglobin concentration - deoxyHb
Time Frame: 5 minutes
|
5 minutes
|
|
Relative total haemoglobin concentration -totalHb
Time Frame: 5 minutes
|
5 minutes
|
|
Temperature
Time Frame: 5 minutes
|
Tissue temperature
|
5 minutes
|
Blood flow
Time Frame: 5 minutes
|
A quantity proportional to the product of the average speed of the blood cells and their number concentration.
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: José E. Cabral Filho, PhD, Instituto de Medicina Integral Prof. Fernando Figueira - Imip
- Study Chair: Rafael M. Miranda, PhD student, Instituto de Medicina Integral Prof. Fernando Figueira - Imip
- Study Chair: João G. Bezerra alves, PhD, Instituto de Medicina Integral Prof. Fernando Figueira - Imip
- Study Chair: Geraldine F. Clough, PhD, University of Southampton - Academic Unit of Human Development and Health
- Principal Investigator: Kaísa T. Diniz, PhD student, Instituto de Medicina Integral Prof. Fernando Figueira - Imip
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Anticipated)
August 1, 2017
Study Completion (Anticipated)
August 1, 2017
Study Registration Dates
First Submitted
July 26, 2016
First Submitted That Met QC Criteria
July 26, 2016
First Posted (Estimate)
July 29, 2016
Study Record Updates
Last Update Posted (Actual)
August 16, 2017
Last Update Submitted That Met QC Criteria
August 12, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 458163/2014-7
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child Development
-
Yale UniversityRobinhood Foundation; Adelphi University; Docs for TotsCompletedSocial Skills | Child Behavior | Child Development | Infant DevelopmentUnited States
-
University of Southern CaliforniaSafe Water and AIDS Project (SWAP); Early Childhood Development Network for...RecruitingChild Behavior | Child Development | Language, ChildKenya
-
Windward Islands Research and Education FoundationGrand Challenges Canada; St. George's University; GRENCASECompletedDevelopment, Child | Behavior, Child | Neurocognition, ChildGrenada
-
Children's Hospital of PhiladelphiaNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingDevelopment Delay | Development, ChildUnited States
-
London School of Hygiene and Tropical MedicineInternational Centre for Diarrhoeal Disease Research, Bangladesh; University... and other collaboratorsActive, not recruitingChild Development | Child Development DisorderBangladesh, Tanzania, Nepal
-
The Hospital for Sick ChildrenAga Khan University; March of DimesCompletedChild Development | Child Mortality | Child Morbidity | Child BehaviourPakistan
-
O-KidiaRecruitingChild Development | Child Development DisorderFrance
-
International Centre for Diarrhoeal Disease Research...UnknownChild Behavior | Child DevelopmentBangladesh
-
University Hospital, RouenRecruitingChild Development | Child Mental Disorder | Adolescent Behavior | Child Behavior Disorders | Behavior, Child | Adolescent Development | Adolescent - Emotional Problem | Child Development DisorderFrance
-
Boston Medical CenterCenter for the Study of Social PolicyCompletedChild Abuse | Parenting | Child Development | Child Rearing | Child NeglectUnited States
Clinical Trials on Kangaroo Position
-
Professor Fernando Figueira Integral Medicine InstituteConselho Nacional de Desenvolvimento Científico e TecnológicoUnknownKangaroo Mother Care MethodBrazil
-
Selcuk UniversityThe Scientific and Technological Research Council of TurkeyCompletedCerebral Oxygenation | Premature | Facilitated Tucking | Kangaroo CareTurkey
-
University of California, DavisNot yet recruitingNutrition Disorder, Infant | Lactation Disorder With Baby DeliveredUnited States
-
Selcuk UniversityCompletedPremature InfantsTurkey
-
Nathalie CharpakHospital Universitario San Ignacio; Laval UniversityCompletedNeurobehavioral Manifestations | Growth Acceleration | Preterm InfantColombia
-
Meir Medical CenterCompletedPreTerm Birth | Stress ReactionIsrael
-
Universidade Metodista de PiracicabaRecruiting
-
Agri Ibrahim Cecen UniversityKahramanmaras Sutcu Imam UniversityCompleted
-
Fatih UniversityUnknownImmaturity | Oral Intolerance | Postnatal AdaptationTurkey
-
Christiana Care Health ServicesCompleted